Insulet Corp (GOV) Stock Price & News

GOV:ETR

Insulet Corp

€126.05

-1.52%

(-1.95) 1D

Sep 3, 5:35:51 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for GOV...

Open

€126.05

High

€126.05

Low

€126.05

Mkt. cap

10.44B

Avg. vol.

67.00

Volume

0.00

52-wk high

€151.05

52-wk low

€113.90

No. of employees

Open

€126.05

High

€126.05

Low

€126.05

Mkt. cap

10.44B

Avg. vol.

67.00

Volume

0.00

52-wk high

€151.05

52-wk low

€113.90

No. of employees

Related stocks

SUU

Strathmore Plus Uranium Corp

Sendero Resources Corp (Vancouver)

News stories

From web sources and news partners

Yahoo Finance

36 minutes ago

Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks

CNBC

2 days ago

After a sell-off, this medical device stock looks like a gift for patient investors

CNBC

2 days ago

Insulet crushed its most recent earnings, but the market's focus on its slightly lowered outlook has presented a buying opportunity

About Insulet Corp

CEOAshley Mcevoy

Employees5.4K

Founded2000

HeadquartersActon, Massachusetts, United States

SectorMedical device

Websiteinsulet.com

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	706.30M	783.80M	761.70M	801.70M
Cost of goods sold	196.20M	215.20M	232.70M	239.10M
Cost of revenue	196.20M	215.20M	232.70M	239.10M
Research and development expenses	77.20M	90.90M	89.70M	88.10M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	315.20M	331.40M	317.20M	344.80M
Operating expense	392.40M	422.30M	406.90M	432.90M
Total operating expenses	588.60M	637.50M	639.60M	672.00M
Operating income	117.70M	146.30M	122.10M	129.70M
Other non operating income	12.10M	1.20M	700.00K	-1.10M
EBT including unusual items	122.80M	140.10M	113.00M	118.70M
EBT excluding unusual items	122.80M	140.10M	113.00M	118.70M
Income tax expense	35.20M	38.50M	21.90M	23.70M
Effective tax rate	28.66%	27.48%	19.38%	19.97%
Other operating expenses	-	-	-	-
Net income	87.60M	101.60M	91.10M	95.00M
Net profit margin	12.40%	12.96%	11.96%	11.85%
Earnings per share	1.24	1.55	1.42	1.66
Interest and investment income	8.60M	5.70M	4.90M	3.60M
Interest expense	-15.60M	-14.90M	-14.70M	-13.50M
Net interest expenses	-7.00M	-9.20M	-9.80M	-9.90M
Depreciation and amortization charges	-	-	-	-
EBITDA	139.70M	170.70M	148.30M	156.40M
Gain or loss from assets sale	-	-	-	-

Ask anything